- Occupational medicine Tuberculosis Malaria Obesity Urban health E-health Youth Civil society Healthcare Respiratory chronic diseases Refugees Tobacco Environmental and non health sector policies Surgery Patient Safety Hepatitis GIS Community participation Prevention and infection control Cardiovascular diseases Nursing Public-private partnerships Redesigning health services Physical activity Vaccines Research and education Migration Bioethics self-management mHealth Diabetes Elderly Healthcare delivery Patients Vulnerable groups Primary health care Information and communication technology Cancer HIV/AIDS Family Medicine social accountability Capacity building New roles and responsibilities of health personnel Physiotherapy Equity and empowerment Health information and technologies Gender Communicable chronic diseases Social determinants Mental health Global health education Foreign policy Sickle cell disease Tropical neglected diseases Emergencies Drugs and diagnostics Non-communicable chronic diseases Lifestyle Healthcare financing Hypertension
Abstract and Sessions by Thematic Tracks (work in progress)
- GHF2006 – PS03 – Most Neglected Diseases on Alternative Approaches to New Drug Development: Two R&D Initiatives
- GHF2006 – PS11 – Public-Private Partnerships: Beneficial or Undermining? on From Basic Research to Drug Delivery: When are PPPS Needed?
- Mako on Children’s Health in Ecologically Polluted Regions: Georgia
- DR: Sohair Abdulla on Adherence to the Diabetics and Hypertensive Treatment Guidelines for Health Workers in Health Facilities: Ibadan, Nigeria
- Hein39 on Affordable Diabetes Care: Cambodia
Therapeutic education Archive
Posted on 18/11/2011 | No CommentsRecurrence of cardiovascular events and mortality remain high after an acute coronary syndrome (ACS), but despite guidelines recommending pharmacologic and lifestyle interventions, up to 30% of patients stop their treatment either partially or totally early with a significant increase in one year mortality. The ELIPS programme is a Geneva driven Swiss multicentric project to improve the prevention of cardiovascular event recurrence after acute coronary syndromes.This multi-level secondary prevention programme targets the treatment of multiple cardiovascular risk factors of patients after an ACS. It is multidimensional because its interventions target not only patients, but also health care providers and the overall health care system with an aim to increase prescription rates of proven efficacious medication, promote lifestyle changes, and ultimately decrease mortality and ACS recurrence.